Rheumatology Advance Access published online on September 16, 2003
Rheumatology, doi:10.1093/rheumatology/keh025
Rheumatology © British Society for Rheumatology 2003; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Papers
1 Division of Angiology, Department of Internal Medicine, University Hospital, Graz, Austria
* Corresponding author. E-mail: marianne.brodmann{at}kfunigraz.ac.at.
Received 22 May 2003
; accepted 28 July 2003
Objective. As one of the diagnostic criteria for giant cell arteritis affecting the temporal arteries (temporal arteritis) is still biopsy-proven vasculitis of the affected artery, the aim of our study was to evaluate the value of a non-invasive procedure, 2-18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (F-18-FDG-PET), in the diagnosis of Horton's disease. Methods. During a period of 10 months, 22 consecutive patients with the clinical diagnosis of giant cell arteritis and a positive hypoechogenic halo in duplex sonography were re-examined with F-18-FDG-PET. Six patients had giant cell arteritis involving both the large arteries and the temporal arteries; five patients showed giant cell arteritis only in the large arteries without concomitant involvement of the temporal arteries, and the remaining 11 patients showed only involvement of the temporal arteries. All patients were examined by sonography and F-18-FDG-PET, which was performed before treatment with corticosteroids. Results. All patients with positive signs of giant cell arteritis in duplex sonography, i.e. a hypoechogenic halo in the large arteries (thoracic, subclavian, axillary, iliac, aorta), also showed elevated FDG uptake in the same vessels, with complete agreement in the anatomical distribution of changes. When positive sonography was limited to the temporal arteries, FDG-PET was completely negative in the temporal arteries and all other arterial locations. Conclusion. PET is not yet suitable for the diagnosis of temporal arteritis and therefore cannot replace invasive biopsy. F-18-FDG-PET is well suited to the demonstration of giant cell arteritis in arteries exceeding 4 mm in diameter.
Key words: F-18-FDG-PET, Giant cell arteritis, Duplex sonography, Temporal arteries, Horton's disease.
The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries
2 Division of Nuclear Medicine and Endocrinology, Department of Internal Medicine, University Hospital, Graz, Austria
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. A. Schmidt, A. Moll, A. Seifert, B. Schicke, E. Gromnica-Ihle, and A. Krause Prognosis of large-vessel giant cell arteritis Rheumatology, September 1, 2008; 47(9): 1406 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tato and U. Hoffmann Giant cell arteritis: a systemic vascular disease Vascular Medicine, May 1, 2008; 13(2): 127 - 140. [Abstract] [PDF]
|
|
|
|
|
|
N. Pipitone, A. Versari, and C. Salvarani Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update Rheumatology, April 1, 2008; 47(4): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Schmidt, A. Seifert, E. Gromnica-Ihle, A. Krause, and A. Natusch Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis Rheumatology, January 1, 2008; 47(1): 96 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Shmerling An 81-year-old woman with temporal arteritis. JAMA, June 7, 2006; 295(21): 2525 - 2534. [Full Text] [PDF]
|
|
|
|
|
|
T. Belhocine The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al. Rheumatology, May 1, 2004; 43(5): 675 - 676. [Full Text] [PDF]
|
|